Alembic Pharmaceuticals Limited (NSE:APLLTD)
India · Delayed Price · Currency is INR 760.75
+3.45 (0.46%)
Jan 28, 2026, 1:33 PM IST
Alembic Pharmaceuticals Employees
Alembic Pharmaceuticals had 16,571 employees as of March 31, 2025. The number of employees increased by 1,713 or 11.53% compared to the previous year.
Employees
16,571
Change (1Y)
1,713
Growth (1Y)
11.53%
Revenue / Employee
4.27M INR
Profits / Employee
382.83K INR
Market Cap
148.86B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 16,571 | 1,713 | 11.53% |
| Mar 31, 2024 | 14,858 | 265 | 1.82% |
| Mar 31, 2023 | 14,593 | 2,377 | 19.46% |
| Mar 31, 2022 | 12,216 | 56 | 0.46% |
| Mar 31, 2021 | 12,160 | 584 | 5.04% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ajanta Pharma | 9,628 |
| Emcure Pharmaceuticals | 6,731 |
| Piramal Pharma | 5,476 |
| Gland Pharma | 4,351 |
| NATCO Pharma | 4,199 |
| Eris Lifesciences | 3,354 |
| Strides Pharma Science | 3,301 |
| Wockhardt | 2,296 |
Alembic Pharmaceuticals News
- 1 day ago - Alembic Pharma receives USFDA approval for Difluprednate Ophthalmic Emulsion 0.05% - Business Upturn
- 1 day ago - Pharma sector stocks today, Jan 27: Syngene down 7%, Natco Pharma falls 2.31%, Alembic Pharma down 1% - Business Upturn
- 9 days ago - Pharma sector stocks fall today: Cipla drops 1.52%, Divi’s Laboratories falls 0.78%, Alembic Pharma down 0.52% - Business Upturn
- 12 days ago - Pharma sector stocks today: Sun Pharma falls 1.43%, Ipca Labs down 1.32%, Alembic Pharma drops 1.08% - Business Upturn
- 16 days ago - Alembic Pharmaceuticals secures USFDA tentative approval for Bosutinib 400 mg tablets - Business Upturn
- 5 weeks ago - Alembic Pharma gets USFDA final approval for Travoprost Ophthalmic Solution - Business Upturn
- 6 weeks ago - Alembic Pharmaceuticals secures USFDA approval for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension, 0.5%/0.3% - Business Upturn
- 2 months ago - Alembic Pharma shares rise over 2% after USFDA nod for Diltiazem Hydrochloride Tablets - Business Upturn